Literature DB >> 5576726

Factors determining cell killing by chemotherapeutic agents in vivo. II. Melphalan, chlorambucil and nitrogen mustard.

L M van Putten, P Lelieveld.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5576726     DOI: 10.1016/0014-2964(71)90089-2

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0014-2964            Impact factor:   9.162


× No keyword cloud information.
  6 in total

1.  Synergistic action of the benzene metabolite hydroquinone on myelopoietic stimulating activity of granulocyte/macrophage colony-stimulating factor in vitro.

Authors:  R D Irons; W S Stillman; D B Colagiovanni; V A Henry
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

2.  Increased cancericidal activity of PTT.119; a new synthetic bis-(2-chloroethyl)amino-L-phenylalanine derivative with carrier amino acids. II. In vivo bioassay.

Authors:  M J Yagi; M Zanjani; J F Holland; J G Bekesi
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

3.  Interphase cell death as related to the cell cycle of melphalan-treated human myeloma cells.

Authors:  J O Fernberg; R Lewensohn; S Skog
Journal:  Med Oncol Tumor Pharmacother       Date:  1991

4.  Exquisite sensitivity of TP53 mutant and basal breast cancers to a dose-dense epirubicin-cyclophosphamide regimen.

Authors:  Philippe Bertheau; Elisabeth Turpin; David S Rickman; Marc Espié; Aurélien de Reyniès; Jean-Paul Feugeas; Louis-François Plassa; Hany Soliman; Mariana Varna; Anne de Roquancourt; Jacqueline Lehmann-Che; Yves Beuzard; Michel Marty; Jean-Louis Misset; Anne Janin; Hugues de Thé
Journal:  PLoS Med       Date:  2007-03       Impact factor: 11.069

5.  Changes in sensitivity to cytotoxic agents occurring during the life history of monolayer cultures of a mouse tumour cell line.

Authors:  P R Twentyman; N M Bleehen
Journal:  Br J Cancer       Date:  1975-04       Impact factor: 7.640

6.  Modulation of the toxicity and antitumour activity of alkylating drugs by steroids.

Authors:  R Shepherd; K R Harrap
Journal:  Br J Cancer       Date:  1982-03       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.